InflaRx NV (IFRX)
1.66
-0.05
(-2.92%)
USD |
NASDAQ |
Jun 09, 16:00
1.665
0.00 (0.00%)
After-Hours: 20:00
InflaRx SG&A Expense (Quarterly) : 3.844M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| MediGene AG | -- |
| BioNTech SE | 176.43M |
| Immatics NV | 16.98M |
| Arrowhead Pharmaceuticals, Inc. | 41.74M |
| Oncolytics Biotech, Inc. | 4.729M |